Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials

OBJECTIVE: To review long-term certolizumab pegol (CZP) safety across all approved indications: rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis (PSO) and Crohn’s disease (CD). METHODS: Data were pooled across 49 UCB-sponsored CZP clinical trials (27 R...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: Curtis, Jeffrey R, Mariette, Xavier, Gaujoux-Viala, Cécile, Blauvelt, Andrew, Kvien, Tore K, Sandborn, William J, Winthrop, Kevin, de Longueville, Marc, Huybrechts, Ivo, Bykerk, Vivian P
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Treatments
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560674/
https://ncbi.nlm.nih.gov/pubmed/31245056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000942
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars